Organization Overview
Alternative names
alendronic acid (fosamax) (1 trial)
anastrozole (arimidex) (3 trials)
autologous hematopoietic stem cells (1 trial)
bacille calmette-guerin (1 trial)
beta carotene (solatene) (1 trial)
bevacizumab (avastin) (5 trials)
bicalutamide (casodex) (6 trials)
bleomycin (blenoxane) (3 trials)
brentuximab vedotin (adcetris) (2 trials)
buserelin (receptal) (4 trials)
capecitabine (xeloda) (4 trials)
carboplatin (paraplatin) (17 trials)
cetuximab (erbitux) (5 trials)
cisplatin (platinol) (34 trials)
cyclophosphamide (cytoxan) (14 trials)
cyclosporine (sandimmune) (1 trial)
cytarabine (cytosar-u) (4 trials)
daratumumab (darzalex) (1 trial)
darolutamide (Nubeqa) (2 trials)
dextromethorphan (delsym) (1 trial)
docetaxel (taxotere) (15 trials)
doxorubicin (Doxil) (16 trials)
durvalumab (imfinzi) (15 trials)
enzalutamide (xtandi) (1 trial)
epirubicin (ellence) (6 trials)
erlotinib (tarceva) (9 trials)
etoposide (vepesid) (8 trials)
exemestane (aromasin) (5 trials)
Filgrastim (neupogen) (3 trials)
fluorouracil (efudex) (17 trials)
flutamide (eulexin) (5 trials)
fulvestrant (faslodex) (3 trials)
gemcitabine (gemzar) (24 trials)
goserelin (zoladex) (5 trials)
ibandronate (boniva) (1 trial)
icosapent ethyl (vascepa) (1 trial)
irinotecan (Camptosar) (6 trials)
lenalidomide (revlimid) (3 trials)
leuprolide (lupron) (5 trials)
levamisole (ergamisol) (1 trial)
melphalan (alkeran) (2 trials)
mitoxantrone (novantrone) (2 trials)
nilutamide (nilandron) (2 trials)
octreotide (sandostatin) (1 trial)
ondansetron (zofran) (1 trial)
oxaliplatin (eloxatin) (6 trials)
paclitaxel (taxol) (22 trials)
panitumumab (vectibix) (2 trials)
pembrolizumab (keytruda) (6 trials)
prednisone (meticorten) (12 trials)
procarbazine (matulane) (3 trials)
regorafenib (stivarga) (1 trial)
risedronate (actonel) (1 trial)
rituximab (rituxan) (9 trials)
sargramostim (leukine) (7 trials)
sitagliptin (januvia) (1 trial)
sorafenib (nexavar) (2 trials)
tamoxifen (nolvadex) (9 trials)
temozolomide (temodar) (7 trials)
temsirolimus (torisel) (7 trials)
thalidomide (Thalomid) (2 trials)
theophylline (synophylate) (1 trial)
topotecan (hycamtin) (2 trials)
trastuzumab (herceptin) (7 trials)
triptorelin (Trelstar) (1 trial)
vinblastine (velban) (6 trials)
vincristine (oncovin) (9 trials)
acetylsalicylic acid (aspirin) (1 trial)
asparaginase (elspar) (1 trial)
azacitidine (vidaza) (1 trial)
bortezomib (velcade) (4 trials)
cobimetinib (cotellic) (1 trial)
crizotinib (xalkori) (1 trial)
dabrafenib (tafinlar) (1 trial)
daunorubicin (cerubidine) (1 trial)
everolimus (zortress) (3 trials)
fludarabine (fludara) (2 trials)
human fecal microbiota (Reybota) (1 trial)
ibrutinib (imbruvica) (2 trials)
lutetium (177Lu) vipivotide tetraxetan (Pluvicto) (1 trial)
lutetium dotatate lu-177 (Lutathera) (1 trial)
mercaptopurine (purinethol) (1 trial)
methylprednisolone (medrol) (1 trial)
olaparib (lynparza) (2 trials)
palbociclib (ibrance) (3 trials)
pegaspargase (oncaspar) (1 trial)
Adenocarcinoma (Phase 3)
Adenocarcinoma, Bronchiolo-Alveolar (Phase 3)
Adenocarcinoma, Clear Cell (Phase 2)
Adenocarcinoma of Lung (Phase 3)
Adenomyoepithelioma (Phase 2)
Adenoviridae Infections (Phase 2)
Anemia (Phase 3)
Anorexia (Phase 3)
Bile Duct Neoplasms (Phase 3)
Bone Marrow Diseases (Phase 3)
Bone Neoplasms (Phase 3)
Brain Neoplasms (Phase 3)
Breast Neoplasms (Phase 3)
Cachexia (Phase 3)
Cancer Pain (Phase 1)
Carcinoma (Phase 3)
Carcinoma, Adenosquamous (Phase 3)
Carcinoma in Situ (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Renal Cell (Phase 3)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 3)
Central Nervous System Neoplasms (Phase 3)
Cholangiocarcinoma (Phase 3)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 3)
Cystadenocarcinoma, Serous (Phase 2)
Deglutition Disorders (Phase 3)
Endometrial Neoplasms (Phase 3)
Esophageal Neoplasms (Phase 3)
Fallopian Tube Neoplasms (Phase 3)
Gallbladder Neoplasms (Phase 3)
Gastrointestinal Stromal Tumors (Phase 3)
Germinoma (Phase 1)
Glioblastoma (Phase 3)
Glioma (Phase 3)
Head and Neck Neoplasms (Phase 3)
Hodgkin Disease (Phase 3)
Infections (Phase 3)
Inflammatory Breast Neoplasms (Phase 2)
Intestinal Neoplasms (Phase 3)
Kidney Neoplasms (Phase 3)
Leukemia (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Liver Neoplasms (Phase 2)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell, Peripheral (Phase 1)
Melanoma (Phase 3)
Mesothelioma (Phase 2)
Multiple Myeloma (Phase 3)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 3)
Nausea (Phase 1)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 3)
Neoplasms, Germ Cell and Embryonal (Phase 1)
Neoplasms, Plasma Cell (Phase 3)
Nervous System Neoplasms (Phase 3)
Neuroblastoma (Phase 1)
Neutropenia (Phase 1)
Oligodendroglioma (Phase 3)
Oropharyngeal Neoplasms (Phase 2)
Osteoporosis (Phase 3)
Ovarian Neoplasms (Phase 3)
Pancoast Syndrome (Phase 2)
Pancreatic Neoplasms (Phase 3)
Parasomnias (Phase 1)
Peritoneal Neoplasms (Phase 2)
Pheochromocytoma (Phase 3)
Plasmacytoma (Phase 3)
Precancerous Conditions (Phase 3)
Preleukemia (Phase 3)
Prostatic Intraepithelial Neoplasia (Phase 3)
Prostatic Neoplasms (Phase 3)
Rectal Neoplasms (Phase 3)
Recurrence (Phase 3)
Salivary Gland Neoplasms (Phase 2)
Sarcoma (Phase 3)
Sleep Wake Disorders (Phase 1)
Small Cell Lung Carcinoma (Phase 3)
Squamous Cell Carcinoma of Head and Neck (Phase 1)
Stomach Neoplasms (Phase 3)
Syndrome (Phase 3)
Triple Negative Breast Neoplasms (Phase 2)
Ulcer (Phase 3)
Ureteral Neoplasms (Phase 3)
Urethral Neoplasms (Phase 3)
Urinary Bladder Neoplasms (Phase 3)
Uterine Cervical Neoplasms (Phase 3)
Vomiting (Phase 3)
Waldenstrom Macroglobulinemia (Phase 2)
Wasting Syndrome (Phase 3)
